Supporting this idea, we previously demonstrated that the relative expression of vIL-2 cytokine transgene and the host wtIL-2 gene expression were equally high in hamster tumors treated with vIL-2 virus, which was sufficient to trigger better tumor control and survival compared to its wtIL-2 virus counterpart [28]. This evidence concerns the gene EZR and neoplasm.